Minocycline inhibits PARP‑1 expression and decreases apoptosis in diabetic retinopathy

Wu,Ying; Chen,Yongdong; Wu,Qiang; Jia,Lili; Du,Xinhua

doi:10.3892/mmr.2015.4064

Minocycline inhibits PARP‑1 expression and decreases apoptosis in diabetic retinopathy

Authors:
- Ying Wu
- Yongdong Chen
- Qiang Wu
- Lili Jia
- Xinhua Du
View Affiliations

Affiliations: Department of Ultrasound, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, P.R. China, Department of Ophthalmology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: July 8, 2015 https://doi.org/10.3892/mmr.2015.4064
Pages: 4887-4894
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the mechanism underlying the effects of minocycline on diabetic retinopathy‑associated cellular apoptosis. A total of 40 Sprague Dawley (SD) rats were used as a diabetic retinopathy model following injection with streptozotocin. Among the 34 rats in which the diabetes model was successfully established, 24 rats were divided into two experimental groups: I and II (T1 and T2, respectively), and orally administered with various doses of minocycline. The remaining 10 rats served as the diabetic retinopathy control group. An additional group of 10 healthy SD rats with comparable weight served as normal controls. The rats in T1 and T2 groups were treated daily for eight consecutive weeks with minocycline at a dose of 2.5 mg/kg and 5 mg/kg, respectively. The mRNA expression levels of poly (ADP‑ribose) polymerase‑1 (PARP‑1) were subsequently measured by reverse transcription‑quantitative polymerase chain reaction, and the protein expression levels of poly‑ADP‑ribose were measured by western blot analysis and immunohistochemistry. Retinal morphology was observed following hematoxylin and eosin staining, and retinal cell apoptosis was measured by terminal deoxynucleotidyl transferase dUTP nick end labeling and caspase‑3 activity assays. The amplitudes of the electroretinogram (ERG) b‑wave and oscillary potentials (OPs) were measured using visual electrophysiology, and compared among the four groups. The results of the present study demonstrated that in the diabetic rats, retinal PARP‑1 gene expression was markedly upregulated, the number of apoptotic cells and the activity levels of caspase‑3 were increased, and the amplitude of the ERG b‑wave and the OPs were markedly lower as compared with the normal rats. Following treatment with minocycline, the abnormal expression of PARP‑1 in the retina was inhibited, and cellular apoptosis was decreased. In conclusion, the results of the present study suggest that PARP‑1 is involved in the development of diabetic retinopathy, and minocycline is able to inhibit PARP‑1 expression and decrease cellular apoptosis, suggesting that minocycline may prove to be a promising drug for the treatment of diabetic retinopathy.

View Figures

View References

1	Engerman RL and Kern TS: Retinopathy in animal models of diabetes. Diabetes Metab Rev. 11:109–120. 1995. View Article : Google Scholar : PubMed/NCBI
2	Mizutani M, Kern TS and Lorenzi M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 97:2883–2890. 1996. View Article : Google Scholar : PubMed/NCBI
3	Hammes HP, Federoff HJ and Brownlee M: Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med. 1:527–534. 1995.PubMed/NCBI
4	Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG and Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 102:783–791. 1998. View Article : Google Scholar : PubMed/NCBI
5	Szabó C and Ohshima H: DNA damage induced by peroxynitrite: Subsequent biological effects. Nitric Oxide. 1:373–385. 1997. View Article : Google Scholar
6	Szabó C and Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci. 19:287–298. 1998. View Article : Google Scholar : PubMed/NCBI
7	Heller B, Wang ZQ, Wagner EF, Radons J, Bürkle A, Fehsel K, Burkart V and Kolb H: Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem. 270:11176–11180. 1995. View Article : Google Scholar : PubMed/NCBI
8	Li GY, Fan B and Su GF: Acute energy reduction induces caspase-dependent apoptosis and activates p53 in retinal ganglion cells (RGC-5). Exp Eye Res. 89:581–589. 2009. View Article : Google Scholar : PubMed/NCBI
9	Zheng L and Kern TS: Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci (Landmark Ed). 14:3974–3987. 2009. View Article : Google Scholar
10	Virág L and Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev. 54:375–429. 2002. View Article : Google Scholar : PubMed/NCBI
11	Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813–820. 2001. View Article : Google Scholar : PubMed/NCBI
12	Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan PH and Koistinaho J: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA. 96:13496–13500. 1999. View Article : Google Scholar : PubMed/NCBI
13	Ryu JK, Franciosi S, Sattayaprasert P, Kim SU and McLarnon JG: Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia. 48:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
14	Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW and Levison SW: Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 54:1559–1565. 2005. View Article : Google Scholar : PubMed/NCBI
15	Vincent JA and Mohr S: Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 56:224–230. 2007. View Article : Google Scholar
16	Chang CJ, Cherng CH, Liou WS and Liao CL: Minocycline partially inhibits caspase-3 activation and photoreceptor degeneration after photic injury. Ophthalmic Res. 37:202–213. 2005. View Article : Google Scholar : PubMed/NCBI
17	Obrosova IG, Minchenko AG, Frank RN, Seigel GM, Zsengeller Z, Pacher P, Stevens MJ and Szabó C: Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med. 14:55–64. 2004.PubMed/NCBI
18	Santiago AR, Cristóvão AJ, Santos PF, Carvalho CM and Ambrósio AF: High glucose induces caspase-independent cell death in retinal neural cells. Neurobiol Dis. 25:464–472. 2007. View Article : Google Scholar : PubMed/NCBI
19	Zhu B, Wang W, Gu Q and Xu X: Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp Eye Res. 86:375–382. 2008. View Article : Google Scholar : PubMed/NCBI
20	Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Naruse K, Sasaki H, Mizuno K, Matsubara A, Kakuta H, et al: Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Exp Physiol. 80:981–989. 1995. View Article : Google Scholar : PubMed/NCBI
21	Wurziger K, Lichtenberger T and Hanitzsch R: On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vision Res. 41:1091–1101. 2001. View Article : Google Scholar : PubMed/NCBI
22	Tzekov R and Arden GB: The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 44:53–60. 1999. View Article : Google Scholar : PubMed/NCBI
23	Ogden TE: The oscillatory waves of the primate electroretinogram. Vision Res. 13:1059–1074. 1973. View Article : Google Scholar : PubMed/NCBI
24	Wachtmeister L and Dowling JE: The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci. 17:1176–1188. 1978.PubMed/NCBI
25	Li Q, Zemel E, Miller B and Perlman I: Early retinal damage in experimental diabetes: Electroretinographical and morphological observations. Exp Eye Res. 74:615–625. 2002. View Article : Google Scholar : PubMed/NCBI
26	Kline RP, Ripps H and Dowling JE: Generation of b-wave currents in the skate retina. Proc Natl Acad Sci USA. 75:5727–5731. 1978. View Article : Google Scholar : PubMed/NCBI
27	Klemp K, Sander B, Brockhoff PB, Vaag A, Lund-Andersen H and Larsen M: The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 46:2620–2626. 2005. View Article : Google Scholar : PubMed/NCBI
28	Chen BH, Jiang DY and Tang LS: Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci. 79:1040–1048. 2006. View Article : Google Scholar : PubMed/NCBI
29	Du Y, Miller CM and Kern TS: Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med. 35:1491–1499. 2003. View Article : Google Scholar : PubMed/NCBI
30	Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB and Obrosova IG: Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Invest Ophthalmol Vis Sci. 50:1778–1790. 2009. View Article : Google Scholar
31	Obrosova IG and Julius UA: Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. Curr Vasc Pharmacol. 3:267–283. 2005. View Article : Google Scholar : PubMed/NCBI
32	Zheng L, Szabó C and Kern TS: Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes. 53:2960–2967. 2004. View Article : Google Scholar : PubMed/NCBI
33	Li GY and Osborne NN: Oxidative-induced apoptosis to an immortalized ganglion cell line is caspase independent but involves the activation of poly(ADP-ribose)polymerase and apoptosis-inducing factor. Brain Res. 1188:35–43. 2008. View Article : Google Scholar
34	Miki K, Uehara N, Shikata N, Matsumura M and Tsubura A: Poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide rescues N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats through preservation of nuclear factor-kappaB activity. Exp Eye Res. 84:285–292. 2007. View Article : Google Scholar
35	Oku H, Goto W, Okuno T, Kobayashi T, Sugiyama T, Ota T, Yoneda S, Hara H and Ikeda T: Effects of poly(ADP-ribose) polymerase inhibitor on NMDA-induced retinal injury. Curr Eye Res. 29:403–411. 2004. View Article : Google Scholar
36	Cukras CA, Petrou P, Chew EY, Meyerle CB and Wong WT: Oral minocycline for the treatment of diabetic macular edema (DME): Results of a phase I/II clinical study. Invest Ophthalmol Vis Sci. 53:3865–3874. 2012. View Article : Google Scholar : PubMed/NCBI
37	Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A and Trauger JW: Antioxidant properties of minocycline: Neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem. 94:819–827. 2005. View Article : Google Scholar : PubMed/NCBI
38	Choi SH, Lee DY, Chung ES, Hong YB, Kim SU and Jin BK: Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem. 95:1755–1765. 2005. View Article : Google Scholar : PubMed/NCBI
39	Sinha-Hikim I, Shen R, Nzenwa I, Gelfand R, Mahata SK and Sinha-Hikim AP: Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis. 16:563–573. 2011. View Article : Google Scholar : PubMed/NCBI
40	Cieslik M, Pyszko J and Strosznajder JB: Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment. Neurochem Int. 62:626–636. 2013. View Article : Google Scholar : PubMed/NCBI